No impact of tenofovir/emtricitabine in estradiol exposure among transwomen on oral PrEP: results from the 12-week drug-drug interaction PrEParadas substudy
Cattani, V ; Jalil, E ; Torres, T ; Cardoso, S ; Eksterman, L ; Castro, C ; Monteiro, L ; Anderson, P ; Wilson, E ; Grinsztejn, B ; Veloso, V ; Estrela, R
Journal of the International AIDS Society, 2021-07, Vol.24 (S4), p.30 [Periódico revisado por pares]John Wiley & Sons, Inc
Texto completo disponível